Covered recipient · General Payments record
KARINA HASING
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,033.68
- Reported across 36 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $433.03 | 17 |
| Education | $89.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $222.91 | 7 |
| ABBVIE INC. | $97.88 | 3 |
| Lilly USA, LLC | $58.47 | 2 |
| Incyte Corporation | $56.54 | 2 |
| ORGANOGENESIS INC. | $33.23 | 1 |
| E.R. Squibb & Sons, L.L.C. | $23.56 | 1 |
| Galderma Laboratories, L.P. | $15.92 | 1 |
| Arcutis Biotherapeutics, Inc. | $14.51 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.91 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107302578 | CMS |
| ABBVIE INC. | $24.20 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107302580 | CMS |
| ABBVIE INC. | $53.77 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107302582 | CMS |
| Arcutis Biotherapeutics, Inc. | $14.51 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121103520 | CMS |
| E.R. Squibb & Sons, L.L.C. | $23.56 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101361764 | CMS |
| Galderma Laboratories, L.P. | $15.92 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145362770 | CMS |
| Incyte Corporation | $26.54 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141278710 | CMS |
| Incyte Corporation | $30.00 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141203473 | CMS |
| Janssen Biotech, Inc. | $89.99 | 01/10/2024 | Education | Undisputed | 01/23/2026 | 1078445358 | CMS |
| Janssen Biotech, Inc. | $25.96 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078449204 | CMS |
| Janssen Biotech, Inc. | $28.07 | 07/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078448644 | CMS |
| Janssen Biotech, Inc. | $24.10 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078444539 | CMS |
| Janssen Biotech, Inc. | $20.00 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078450513 | CMS |
| Janssen Biotech, Inc. | $9.22 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078444227 | CMS |
| Janssen Biotech, Inc. | $25.57 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078449035 | CMS |
| Lilly USA, LLC | $24.17 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135648669 | CMS |
| Lilly USA, LLC | $34.30 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135733198 | CMS |
| Organogenesis Inc. | $33.23 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145458458 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.